| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
American Journal of Pathology, Vol 151, 1619-1628, Copyright © 1997 by American Society for Investigative Pathology
REGULAR ARTICLES |
PW Finch, F Murphy, I Cardinale and JG Krueger
Derald H. Ruttenberg Cancer Center, Mount Sinai School of Medicine, New York, New York 10029, USA.
One of the biological characteristics of psoriasis is excessive flaking of the skin. This is directly related to the marked hyperplasia of epidermal keratinocytes and to incomplete epidermal differentiation. Keratinocyte growth factor (KGF), a potent mitogen for human keratinocytes, is expressed by stromal cells. Alterations in the KGF signaling pathway might account for the epidermal hyperplasia associated with psoriasis. To test this hypothesis, we investigated the expression of KGF and its receptor (KGFR) in psoriasis tissue. KGF and KGFR mRNA levels were found to be frequently elevated in psoriatic skin specimens as compared with normal skin. Increased KGF transcript expression was localized to the dermal layer of the involved skin specimen using in situ hybridization. In contrast, KGFR transcript and protein expression was localized to the basal layer of keratinocytes in normal skin and to the basal and suprabasal layers of the psoriatic epidermis, coincident with the expanded proliferative keratinocyte pool. To identify molecules that might regulate KGFR expression we investigated the effects of various pharmacological agents and cytokines on KGFR synthesis by keratinocytes. Phorbol ester, interleukin-6, interferon-gamma, and ultraviolet B (UVB) treatment all led to substantial down-regulation of KGFR expression. The down- regulation of KGFR synthesis by UVB suggests a possible mechanism for the antiproliferative action of this agent in the treatment of psoriasis. Taken together, these results suggest that increased KGFR- mediated signaling in keratinocytes in the lesional epidermis might account in part for the epidermal hyperplasia in psoriasis.
This article has been cited by other articles:
![]() |
P. Koria and S. T. Andreadis KGF promotes integrin {alpha}5 expression through CCAAT/enhancer-binding protein-beta Am J Physiol Cell Physiol, September 1, 2007; 293(3): C1020 - C1031. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Cho, T. Ishiwata, E. Uchida, N. Nakazawa, M. Korc, Z. Naito, and T. Tajiri Enhanced Expression of Keratinocyte Growth Factor and Its Receptor Correlates with Venous Invasion in Pancreatic Cancer Am. J. Pathol., June 1, 2007; 170(6): 1964 - 1974. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. K. Yeh, M. Igarashi, A. V. Eliseenkova, A. N. Plotnikov, I. Sher, D. Ron, S. A. Aaronson, and M. Mohammadi Structural basis by which alternative splicing confers specificity in fibroblast growth factor receptors PNAS, March 4, 2003; 100(5): 2266 - 2271. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. E. Putnins, A.-R. Sanaie, Q. Wu, and J. D. Firth Induction of Keratinocyte Growth Factor 1 Expression by Lipopolysaccharide Is Regulated by CD-14 and Toll-Like Receptors 2 and 4 Infect. Immun., December 1, 2002; 70(12): 6541 - 6548. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.J. Das, H.N. Newman, and I. Olsen Keratinocyte Growth Factor Receptor is Up-regulated in Cyclosporin A-induced Gingival Hyperplasia J. Dent. Res., October 1, 2002; 81(10): 683 - 687. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. T. ANDREADIS, K. E. HAMOEN, M. L. YARMUSH, and J. R. MORGAN Keratinocyte growth factor induces hyperproliferation and delays differentiation in a skin equivalent model system FASEB J, April 1, 2001; 15(6): 898 - 906. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Capone, V. Visco, F. Belleudi, C. Marchese, G. Cardinali, M. Bellocci, M. Picardo, L. Frati, and M. R. Torrisi Up-Modulation of the Expression of Functional Keratinocyte Growth Factor Receptors Induced by High Cell Density in the Human Keratinocyte HaCaT Cell Line Cell Growth Differ., November 1, 2000; 11(11): 607 - 614. [Abstract] [Full Text] |
||||
![]() |
P W Finch and A L Cheng Analysis of the cellular basis of keratinocyte growth factor overexpression in inflammatory bowel disease Gut, December 1, 1999; 45(6): 848 - 855. [Abstract] [Full Text] [PDF] |
||||
![]() |
P Gillis, U Savla, O. Volpert, B Jimenez, C. Waters, R. Panos, and N. Bouck Keratinocyte growth factor induces angiogenesis and protects endothelial barrier function J. Cell Sci., January 6, 1999; 112(12): 2049 - 2057. [Abstract] [PDF] |
||||
![]() |
J. Zhou, K. Wu, C. L. Fernandes, A. L. Cheng, and P. W. Finch Keratinocyte Growth Factor Down-regulates Expression of the Sucrase-Isomaltase Gene in Caco-2 Intestinal Epithelial Cells J. Biol. Chem., December 11, 1998; 273(50): 33367 - 33373. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Ishiwata, H. Friess, M. W. Buchler, M. E. Lopez, and M. Korc Characterization of Keratinocyte Growth Factor and Receptor Expression in Human Pancreatic Cancer Am. J. Pathol., July 1, 1998; 153(1): 213 - 222. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Igarashi, P. W. Finch, and S. A. Aaronson Characterization of Recombinant Human Fibroblast Growth Factor (FGF)-10 Reveals Functional Similarities with Keratinocyte Growth Factor (FGF-7) J. Biol. Chem., May 22, 1998; 273(21): 13230 - 13235. [Abstract] [Full Text] [PDF] |
||||
![]() |
C Marchese, P Mancini, F Belleudi, A Felici, R Gradini, T Sansolini, L Frati, and M. Torrisi Receptor-mediated endocytosis of keratinocyte growth factor J. Cell Sci., January 12, 1998; 111(23): 3517 - 3527. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |